- Home
- TASK vs INVA Comparison
TASK vs INVA Comparison
Compare TASK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TASK
- INVA
- Stock Information
- Founded
- TASK 2008
- INVA 1996
- Country
- TASK United States
- INVA United States
- Employees
- TASK N/A
- INVA N/A
- Industry
- TASK Retail: Computer Software & Peripheral Equipment
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- TASK Technology
- INVA Health Care
- Exchange
- TASK Nasdaq
- INVA Nasdaq
- Market Cap
- TASK 1.1B
- INVA 1.1B
- IPO Year
- TASK 2021
- INVA 2004
- Fundamental
- Price
- TASK $13.04
- INVA $20.81
- Analyst Decision
- TASK Buy
- INVA Buy
- Analyst Count
- TASK 4
- INVA 5
- Target Price
- TASK $17.25
- INVA $36.60
- AVG Volume (30 Days)
- TASK 481.6K
- INVA 804.4K
- Earning Date
- TASK 11-07-2025
- INVA 11-05-2025
- Dividend Yield
- TASK N/A
- INVA N/A
- EPS Growth
- TASK 48.21
- INVA 53.96
- EPS
- TASK 0.88
- INVA 1.52
- Revenue
- TASK $1,144,833,000.00
- INVA $388,521,000.00
- Revenue This Year
- TASK $20.00
- INVA $7.98
- Revenue Next Year
- TASK $11.47
- INVA $11.60
- P/E Ratio
- TASK $14.83
- INVA $13.68
- Revenue Growth
- TASK 19.88
- INVA 10.14
- 52 Week Low
- TASK $11.26
- INVA $16.52
- 52 Week High
- TASK $19.60
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- TASK 36.69
- INVA 77.26
- Support Level
- TASK $12.41
- INVA $17.87
- Resistance Level
- TASK $14.36
- INVA $18.31
- Average True Range (ATR)
- TASK 0.48
- INVA 0.67
- MACD
- TASK 0.04
- INVA 0.39
- Stochastic Oscillator
- TASK 31.36
- INVA 95.96
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.